Hub service model ensuring that GSK BioPharma (Pharma and Vaccines Business and R&D) engages HCP/Os and External Experts... Preferred Experience Pharma/Science Industry experience Knowledge of R&D clinical development and/or medical affairs...
process as part of the enterprise External Expert Engagement Hub service model ensuring that GSK BioPharma (Pharma... matrix environment Preferred Experience Pharma/Science Industry experience Knowledge of R&D clinical development...
Jeffrey Goldberg, The Atlantic's editor in chief, was mistakenly added to a chat of senior Trump officials. Now he's a political target. Continue Reading »
Before Gensol’s stock crashed 80%, insiders sold at the peak—months before rating agencies flagged concerns. Here’s how tracking insider activity can give investors an early warning. Continue Reading »
IRM Energy Ltd. shares surged 14% after announcing a five-year RLNG supply agreement with Shell Energy India. The deal aims to provide stable gas supplies for industrial clients, enhancing sourcing capabilities while promoting cleaner fuel solutions and supporting India's energy security. Continue Reading »
Global markets today: The Oracle of Omaha Warren Buffett doesn’t claim to be an expert at market timing, but he knows when stocks are expensive. Continue Reading »
Investors often believe in the strategy of buying blue-chip stocks and ignoring them. However, expert Devina Mehra argues this is a myth, highlighting the changing nature of blue-chip definitions and the influence of market dynamics on company longevity. Continue Reading »
Once overshadowed by gold, silver is emerging as a favoured asset. Investors are pouring into silver ETFs, betting on both its safe-haven appeal and industrial demand. Continue Reading »
Studds IPO: Studds Accessories Limited has filed its draft red herring prospectus with SEBI for an IPO. The company aims to raise ₹98 crore and sell up to 77.9 lakh shares. It is a leading two-wheeler helmet manufacturer in India and globally recognized. Continue Reading »
Newgen Software Technologies' shares rose 7% to ₹1,037 after securing a $1.28 million ECM contract. Despite a 38% plunge in January due to weak earnings, the stock has rebounded, gaining 10.22% in March but is still down 42% from its January peak. Continue Reading »